ATE366727T1 - Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren - Google Patents

Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren

Info

Publication number
ATE366727T1
ATE366727T1 AT02793527T AT02793527T ATE366727T1 AT E366727 T1 ATE366727 T1 AT E366727T1 AT 02793527 T AT02793527 T AT 02793527T AT 02793527 T AT02793527 T AT 02793527T AT E366727 T1 ATE366727 T1 AT E366727T1
Authority
AT
Austria
Prior art keywords
sub
diaryl
highly selective
inhibitors
selective cyclooxygenase
Prior art date
Application number
AT02793527T
Other languages
English (en)
Inventor
Il-Hwan Cho
Jee-Woong Lim
J Noh
J Kim
S Park
Hyung-Chul Ryu
Je-Hak Kim
So-Young Wang
Dal-Hyun Kim
C Lyu
Original Assignee
Cj Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Corp filed Critical Cj Corp
Application granted granted Critical
Publication of ATE366727T1 publication Critical patent/ATE366727T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Detergent Compositions (AREA)
AT02793527T 2001-12-28 2002-12-27 Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren ATE366727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010086698A KR100686537B1 (ko) 2001-12-28 2001-12-28 사이클로옥시게나제-2 의 저해제로서 선택성이 뛰어난디아릴 1,2,4-트리아졸 유도체

Publications (1)

Publication Number Publication Date
ATE366727T1 true ATE366727T1 (de) 2007-08-15

Family

ID=19717755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793527T ATE366727T1 (de) 2001-12-28 2002-12-27 Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren

Country Status (10)

Country Link
US (2) US7169929B2 (de)
EP (1) EP1458706B1 (de)
JP (1) JP4242286B2 (de)
KR (1) KR100686537B1 (de)
CN (1) CN1290842C (de)
AT (1) ATE366727T1 (de)
AU (1) AU2002359985A1 (de)
DE (1) DE60221152T2 (de)
ES (1) ES2286321T3 (de)
WO (1) WO2003055875A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491317B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470076B1 (ko) * 2002-11-27 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100576343B1 (ko) * 2004-07-22 2006-05-03 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
WO2006124687A1 (en) * 2005-05-12 2006-11-23 University Of Medicine And Dentistry Of New Jersey Opioid receptor subtype-selective agents
CN102464652B (zh) 2010-11-02 2013-08-28 北京欧博方医药科技有限公司 咪唑衍生物、制备方法及用途
CN103347886A (zh) * 2010-11-26 2013-10-09 株式会社半导体能源研究所 有机金属配合物、发光元件、发光装置、电子设备以及照明装置
CN118638055B (zh) * 2024-05-28 2026-05-29 青岛科技大学 一种连接杂环苯磺酰胺类衍生物及合成方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US75507A (en) * 1868-03-17 ingk adams
US125368A (en) * 1872-04-02 Improvement in railway rails
ATE278399T1 (de) * 1995-07-21 2004-10-15 Savvipharm Inc Orotatsalze von 5-amino- oder substituierten amino-1,2,3-triazolen zur behandlung von neoplasmen
AU730211B2 (en) * 1996-11-19 2001-03-01 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
KR20010006443A (ko) * 1997-04-18 2001-01-26 쥐.디. 씨얼리 앤드 컴퍼니 심장혈관 질환 예방에의 시클로 옥시게나제-2 억제제 사용방법
TW438784B (en) * 1997-08-29 2001-06-07 Ssp Co Ltd Triazole derivative or salt thereof and pharmaceutical composition for treating mycosis containing the same
ATE281458T1 (de) 1997-09-05 2004-11-15 Glaxo Group Ltd Pharmazeutische zusammensetzung, enthaltend 2,3- diaryl-pyrazolo(1,5-b)pyridazin derivate
EP1099695A1 (de) * 1999-11-09 2001-05-16 Laboratoire Theramex S.A. 5-Aryl-1H-1,2,4-triazolverbindungen als Cyclooxygenase-2 Inhibitoren und diese enthaltende pharmazeutische Zusammensetzungen
DE60018792T2 (de) * 1999-12-03 2006-01-26 Pfizer Products Inc., Groton Heterocyclo-alkylsulfonylpyrazolderivate zur verwendung als anti-imflammatorische oder analgetische verbindungen
EP1142889A1 (de) * 2000-04-03 2001-10-10 Pfizer Products Inc. Pyrazolderivate als entzündungs-/schmerzhemmende Mittel
CA2390181A1 (en) * 2001-07-05 2003-01-05 Andrei Shavnya Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents
ES2240661T3 (es) * 2001-07-05 2005-10-16 Pfizer Products Inc. Sulfonil-heteroaril-triazoles como agentes antiinflamatorios y analgesicos.
KR100467668B1 (ko) * 2002-08-07 2005-01-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물

Also Published As

Publication number Publication date
DE60221152T2 (de) 2008-03-20
EP1458706B1 (de) 2007-07-11
JP4242286B2 (ja) 2009-03-25
DE60221152D1 (en) 2007-08-23
CN1290842C (zh) 2006-12-20
WO2003055875A1 (en) 2003-07-10
EP1458706A4 (de) 2005-06-08
US7169929B2 (en) 2007-01-30
KR100686537B1 (ko) 2007-02-27
JP2005518396A (ja) 2005-06-23
AU2002359985A1 (en) 2003-07-15
KR20030056481A (ko) 2003-07-04
ES2286321T3 (es) 2007-12-01
EP1458706A1 (de) 2004-09-22
US7135572B2 (en) 2006-11-14
CN1608060A (zh) 2005-04-20
US20060009495A1 (en) 2006-01-12
US20050075373A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
YU5503A (sh) Nesteroidni supresori zapaljenja
ATE331708T1 (de) Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren
DE69919212D1 (de) Aromatische amiden
NO20034291L (no) 2-aminopropanolderivater
ATE389638T1 (de) Aminobenzamidderivate als inhibitoren der glycogensynthasekinase-3-
BG106585A (en) Kinase inhibitors as therapeutic agents
ATE374765T1 (de) Substituierte heterocyclische amide
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
SE0000540D0 (sv) New compounds
DK0931788T3 (da) Metalloproteasehæmmere
SE0004245D0 (sv) Novel compounds and their use
BR0313969A (pt) Inibidores de oxitocina
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
DE60229420D1 (de) Neue metallproteinaseinhibitoren
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE308540T1 (de) Antithrombosemittel
NO20015892D0 (no) Inhibitorer av metallproteinaser
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
DE60221152D1 (en) Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE287403T1 (de) 6-phenylbenzonaphthyidine
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
DE60228134D1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties